AMERICAN JOURNAL OF RHINOLOGY & ALLERGY, cilt.26, sa.5, 2012 (SCI-Expanded)
Background: Insufficient response to treatment and declining quality of life illustrate the continuing need to find new treatment modalities for allergic rhinitis (AR). The purpose of this study was to assess how escitalopram affects symptoms and quality of life among AR patients.